Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

Abstract

OBJECTIVES:

To define the biomarkers associated with lymphoproliferation in primary Sjögren's syndrome (pSS) by distinguishing in separate groups the two best-recognized non-malignant prelymphomatous conditions in pSS, i.e., salivary gland swelling and cryoglobulinemic vasculitis (CV).

METHODS:

A multicenter study was conducted in 5 centres. Patients fulfilled the following criteria: (1) positive AECG criteria for pSS, (2) serum cryoglobulins evaluated, and (3) lack of hepatitis C virus infection. Four groups were distinguished and analysed by multinomial analyses: (1) B-cell non-Hodgkin's lymphoma (NHL), (2) CV without lymphoma, (3) salivary swelling without NHL (SW), and (4) pSS patients without NHL or prelymphomatous conditions.

RESULTS:

Six hundred and sixty-one patients were studied. Group 1/NHL comprised 40/661 (6.1%) patients, Group 2/CV 17/661 (2.6%), Group 3/SW 180/661 (27.2%), and Group 4/pSS controls 424/661 (64.1%). Low C4 [relative-risk ratio (RRR) 8.3], cryoglobulins (RRR 6.8), anti-La antibodies (RRR 5.2), and leukopenia (RRR 3.3) were the variables distinguishing Group 1/NHL from Group 4/Controls. As concerns the subset of patients with prelymphomatous conditions, the absence of these biomarkers provided a negative predictive value for lymphoma of 98% in patients with salivary swelling (Group 3/SW). Additional follow-up studies in patients with SW confirmed the high risk of lymphoma when at least 2/4 biomarkers were positive.

CONCLUSIONS:

Lymphoma-associated biomarkers were defined in a multicentre series of well-characterized patients with pSS, by dissecting the cohort in the pSS-associated prelymphomatous conditions. Notably, it was demonstrated for the first time that among the pSS patients with salivary swelling, only those with positive biomarkers present an increased risk of lymphoma evolution.

• Authors: Luca Quartuccio, Miriam Isola, Chiara Baldini, Roberta Priori, Elena Bartoloni Bocci, Francesco Carubbi, Marta Maset, Giorgia Gregoraci, Vincenzo Della Mea, Sara Salvin, Ginevra De Marchi, Nicoletta Luciano, Serena Colafrancesco, Alessia Alunno, Roberto Giacomelli, Roberto Gerli, Guido Valesini, Stefano Bombardieri, Salvatore De Vita
• Journal: Journal of autoimmunity (J Autoimmun) Vol. 51 Pg. 75-80 (Jun 2014) ISSN: 1095-9157 [Electronic] England
• PMID: 24231556 (Publication Type: Journal Article, Multicenter Study)
• Copyright: Copyright © 2013 Elsevier Ltd. All rights reserved.

Chemical References

• Biomarkers

Topics

• Adult
• Biomarkers (metabolism)
• Female
• Follow-Up Studies
• Humans
• Lymphoma (diagnosis, etiology)
• Male
• Middle Aged
• Precancerous Conditions (pathology)
• Risk
• Sjogren's Syndrome (complications, immunology)